10-year follow-up of gene-modified adenoviral-based therapy in 146 non-small-cell lung cancer patients
Authors:
- 18 May 2007
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 14 (8) , 762-763
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Second-line treatment for advanced non-small cell lung cancer: A systematic reviewLung Cancer, 2006
- Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancerCancer Gene Therapy, 2006
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I studyMolecular Therapy, 2005
- Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With ChemotherapyJournal of Clinical Oncology, 2004
- Granulocyte-Macrophage Colony-Stimulating Factor Gene-Modified Autologous Tumor Vaccines in Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2004
- TNFerade Biologic, an Adenovector With a Radiation-Inducible Promoter, Carrying the Human Tumor Necrosis Factor Alpha Gene: A Phase I Study in Patients With Solid TumorsJournal of Clinical Oncology, 2004
- Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patientsCancer Gene Therapy, 2003
- Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000